Top Markets
Coin of the day
NuVasive, Inc. NuVasive, Inc.

NuVasive, Inc.

NUVA
Clasificación en acciones #6445
NuVasive, Inc. is a medical technology firm focused on creating, producing, and... NuVasive, Inc. is a medical technology firm focused on creating, producing, and distributing comprehensive procedural solutions for spinal operations. The company offers a range of surgical access instruments, such as the Maxcess integrated split-blade retractor system, which facilitates less-invasive surgical approaches by significantly reducing soft tissue disruption during spinal procedures. Additionally, NuVasive manufactures specialized spinal implants designed to improve spinal fusion by optimizing the osseointegration and biomechanical characteristics of materials like porous titanium and porous polyetheretherketone. Its fixation systems are engineered to help maintain and re-establish proper patient alignment. Other offerings include cervical total disc replacement technology, used in cervical spinal fusion surgery, and advanced neuromonitoring systems. These systems leverage proprietary software for nerve detection and avoidance, complemented by comprehensive intraoperative neuromonitoring services and support. The Pulse platform, a distinctive software ecosystem, unifies various hardware technologies into a compact, integrated system within the operating room environment. Furthermore, NuVasive supplies expandable growing rod implant systems for managing early-onset scoliosis, along with diverse biologics crucial for supporting spinal fusion or bone healing. Another key product is Precice, an intramedullary implant device that employs MAGEC technology for the non-invasive lengthening of the femur and tibia. The company also offers both onsite and remote monitoring solutions for the neurological systems of patients undergoing spinal and brain-related surgical interventions. NuVasive distributes its products to a broad client base, including patients, surgeons, hospitals, and insurers, through a multi-channel sales approach encompassing independent sales agents, its own sales force, and distributors, operating across the United States and global markets. Established in 1997, NuVasive, Inc. maintains its corporate headquarters in San Diego, California.
Precio por acción
$39.75
Última sincronización: 2023-09-08
Capitalización bursátil
$2.04B
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio NuVasive, Inc. (NUVA)

Categoría

Ratio P/E de NuVasive, Inc. (NUVA)
Ratio P/E al 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de NuVasive, Inc., el P/E actual (TTM) de la empresa es 0. Al final de 2026, la empresa tenía un P/E de 0.
Historial del ratio P/E de NuVasive, Inc. desde 2026 hasta 2026
Relación P/E al final de cada año
Año Ratio P/E Cambiar
Not enough data for the provided dates.
Relación P/E para empresas similares o competidores
Empresa P/E Ratio Diferencia del P/E Ratio País
35.77 -
US
34.86 -
US
21.39 -
IE
20.90 -
US
- -
DE
¿Cómo leer un P/E ratio?

El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.

Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.

Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.